🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalGerman private insurance (PKV) vs statutory (GKV) — my results so far Page 3

German private insurance (PKV) vs statutory (GKV) — my results so far

JenPlateau Thu, Apr 18, 2024 at 5:12 PM 14 replies 2,230 viewsPage 3 of 3
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
Apr 20, 2024 at 3:14 PM#11
TrialNerd_Beth said:
Insurance update relevant to cost and coverage: I just got my prior auth approved through Blue Cross after 3 attempts.
TrialNerd_Beth said:
...regarding the discontinuation data for cost and coverage...

I want to reframe the discontinuation narrative. We don't say "insulin fails because blood sugar rises when you stop it." We don't say "antihypertensives fail because BP goes up without them."

Why do we apply different logic to anti-obesity medications? The answer is stigma. We still, unconsciously, believe obesity is about willpower rather than biology. The discontinuation data actually PROVES it's a chronic biological condition requiring ongoing treatment.

This reframing isn't semantic — it has implications for insurance coverage, treatment duration, and patient expectations.

Last edited: Apr 20, 2024 at 9:14 PM
14 14kim_atl_prep, sarah_TO, wendy_avl and 11 others
Reply Quote Save Share Report
MounjBrad
Member
278
890
Oct 2024
Kentucky
Apr 22, 2024 at 8:17 AM#12
carl_compliance said:
NurseKim_ATL said: ...my insurance denied cost and coverage coverage because...

Thank you — that is the clearest version of this I have read, and I have read a lot of them.

13 13ben_calgary, patPC_UT, Dr.DermMIA and 10 others
Reply Quote Save Share Report
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Apr 24, 2024 at 1:21 AM#13
TrialNerd_Beth said:
Insurance update relevant to cost and coverage: I just got my prior auth approved through Blue Cross after 3 attempts.

Insurance coverage hack for cost and coverage: if your insurance denies brand Wegovy/Ozempic, consider these alternatives:

  1. Prior authorization appeal with peer-to-peer review
  2. Manufacturer copay card (for commercial insurance)
  3. Patient assistance programs (Novo Nordisk, Eli Lilly)
  4. Compounded medication from a 503B pharmacy ($132/month)
  5. Canadian pharmacy (requires prescription, ~40-60% savings)

Don't let cost prevent access to effective treatment. There are options at every price point.

12 12HealthEcon_DC, PedsEndoPhilly, SleepDoc_PDX and 9 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
DoseLogDan
Member
201
567
Feb 2025
Montana
Apr 25, 2024 at 6:26 PM#14
JenPlateau said:
The list price and the price I actually pay differ by a factor of six depending on which of four routes I use, and none of that is transparent from…

Telehealth prescriber review for cost and coverage: I've used 3 different telehealth platforms to get my GLP-1 prescription. Comparison:

FeaturePlatform APlatform BPlatform C
Initial Consult$58$88$0
Monthly Follow-up$38Included$58
Prescription SpeedSame day24-48 hoursSame day
Lab MonitoringRequiredOptionalRequired

I settled on the one that required labs — it shows they care about safety, not just prescribing volume.

11 11sophie_paris, mel_PDX, Dr.AddMedPHL and 8 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Apr 27, 2024 at 11:32 AM#15

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again. No action needed from anybody.

10 10PurityPaulOR, MaxMetOK, MounjBrad and 7 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register